Ares Genetics GmbH
About:
Ares Genetics develops Artificial Intelligence informed DNA-Sequencing Tests to revolutionize Infectious Disease and Drug Resistance Testing
Website: http://www.ares-genetics.com
Top Investors: Vienna Business Agency
Description:
OpGen uses molecular microbiology and bioinformatics to create diagnostic solutions that will improve the treatment of life-threatening, drug-resistant infections. By employing precision medicine to guide antibiotic therapy selection and aid enhance antibiotic stewardship, the business hopes to drastically revolutionize patient care.
1.3M EUR
$1M to $10M
Vienna, Wien, Austria
2017-01-01
contact(AT)ares-genetics.com
Arne Materna
11-50
2019-01-08
Private
© 2025 bioDAO.ai